ICRC-Weyer
ICRC-Weyer is recorded as a service provider in 11 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 11 of 11 trials · Latest update first
Phase II-III study to assess the efficacy and safety of subcutaneous cluster-immunotherapy in patients suffering from birch pollen allergy
Sponsor ROXALL Medizin GmbH
- Start (EU)
- Latest update
- Estimated end
Phase II-III study to assess the efficacy and safety of sublingual immunotherapy in patients suffering from birch pollen allergy
Sponsor ROXALL Medizin GmbH
- Start (EU)
- Latest update
- Estimated end
International, multicenter, blinded phase III clinical trial to assess the diagnostic efficacy of the skin prick test from ROXALL (SPT-RX) with different allergen extract solutions for in vivo diagnosis of IgE mediated allergies
Sponsor ROXALL Medizin GmbH
- Start (EU)
- Not reported
- Latest update
- Estimated end
Phase II-III study to assess the efficacy and safety of subcutaneous cluster-immunotherapy in patients suffering from house dust mite allergy
Sponsor ROXALL Medizin GmbH
- Start (EU)
- Latest update
- Estimated end
Phase II-III study to assess the efficacy and safety of sublingual immunotherapy in patients suffering from house dust mite allergy. A prospective, international, randomized, double-blind, placebo-controlled, multicentre, phase II-III trial.
Sponsor ROXALL Medizin GmbH
- Start (EU)
- Latest update
- Estimated end
A Phase 2a Safety, Tolerability, and Pharmacodynamic Study of OMT-28 in PMD patients with myopathy and/or cardiomyopathy and inflammation (PMD-OPTION)
Sponsor OMEICOS Therapeutics GmbH
- Start (EU)
- Latest update
- Estimated end
- Not reported
Phase II-III study to assess the efficacy and safety of subcutaneous cluster-immunotherapy in patients suffering from Olea europaea pollen allergy
Sponsor ROXALL Medizin GmbH
- Start (EU)
- Latest update
- Estimated end
Phase II-III study to assess the efficacy and safety of subcutaneous cluster-immunotherapy in patients suffering from grass pollen allergy
Sponsor ROXALL Medizin GmbH
- Start (EU)
- Latest update
- Estimated end
Phase II-III study to assess the efficacy and safety of sublingual immunotherapy in patients suffering from grass pollen allergy
Sponsor ROXALL Medizin GmbH
- Start (EU)
- Latest update
- Estimated end
Phase II-III study to assess efficacy and safety of sublingual immunotherapy in patients suffering from grass pollen allergy
Sponsor ROXALL Medizin GmbH
- Start (EU)
- Latest update
- Estimated end
Phase II-III study to assess the efficacy and safety of sublingual immunotherapy in patients suffering from birch pollen allergy
Sponsor ROXALL Medizin GmbH
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for ICRC-Weyer?
The 2026-10-09 snapshot links ICRC-Weyer to 11 distinct CTIS trials. Recorded services include Data management, Statistical analysis, Electronic data capture, Medical writing. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for ICRC-Weyer?
The most frequently recorded therapeutic areas are Allergy, Immunology, Respiratory. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to ICRC-Weyer conducted?
The linked trials record locations in 6 countries, including Germany, Spain, Italy, Kazakhstan, Netherlands. These are trial locations, not confirmed office locations or countries where ICRC-Weyer delivered services.
What can this page tell me about ICRC-Weyer's trial experience?
Browse 11 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under ICRC-Weyer. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- ICRC-Weyer GmbH